Strengths

● According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.

● The earnings growth currently anticipated by analysts for the coming years is particularly strong.

● Before interest, taxes, depreciation and amortization, the company's margins are particularly high.

● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● Consensus analysts have strongly revised their opinion of the company over the past 12 months.


Weaknesses

● With an expected P/E ratio at 575.33 and 266.84 respectively for both the current and next fiscal years, the company operates with high earnings multiples.

● The company's "enterprise value to sales" ratio is among the highest in the world.

● The company appears highly valued given the size of its balance sheet.

● The company is highly valued given the cash flows generated by its activity.

● The company is not the most generous with respect to shareholders' compensation.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

● Revenue estimates are regularly revised downwards for the current and coming years.

● For the past year, analysts have significantly revised downwards their profit estimates.

● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

● The overall consensus opinion of analysts has deteriorated sharply over the past four months.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.